
Sunday, July 06, 2025 2:43:43 AM
Recent IOVA News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2025 08:05:15 PM
- Iovance Biotherapeutics Appoints Marc R. Theoret, M.D. as Senior Vice President, Regulatory Strategy • GlobeNewswire Inc. • 07/10/2025 08:01:00 PM
- The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Iovance Biotherapeutics, Inc.(IOVA) Shareholders • PR Newswire (US) • 07/10/2025 01:00:00 PM
- IOVA Shareholders Have the Right to Lead the Iovance Biotherapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ELV • PR Newswire (US) • 07/07/2025 02:04:00 PM
- The Gross Law Firm Notifies Iovance Biotherapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline • PR Newswire (US) • 07/07/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/03/2025 08:05:53 PM
- The Gross Law Firm Reminds Iovance Biotherapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 14, 2025 - IOVA • PR Newswire (US) • 07/03/2025 01:00:00 PM
- IOVA Shareholders Have the Right to Lead the Iovance Biotherapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ELV • PR Newswire (US) • 07/02/2025 01:24:00 PM
- July 14, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against IOVA • PR Newswire (US) • 06/30/2025 01:00:00 PM
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 14, 2025 in Iovance Lawsuit - IOVA • PR Newswire (US) • 06/26/2025 01:00:00 PM
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 06/23/2025 08:05:00 PM
- Iovance Biotherapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - IOVA • PR Newswire (US) • 06/23/2025 01:00:00 PM
- Contact The Gross Law Firm by July 14, 2025 Deadline to Join Class Action Against Iovance Biotherapeutics, Inc.(IOVA) • PR Newswire (US) • 06/19/2025 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2025 08:09:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2025 08:06:08 PM
- IOVA Shareholders Have the Right to Lead the Iovance Biotherapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ELV • PR Newswire (US) • 06/16/2025 03:58:00 PM
- Shareholders that lost money on Iovance Biotherapeutics, Inc.(IOVA) should contact The Gross Law Firm about pending Class Action - IOVA • PR Newswire (US) • 06/16/2025 09:45:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2025 09:15:24 PM
- IOVA Shareholders Have the Right to Lead the Iovance Biotherapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ELV • PR Newswire (US) • 06/13/2025 02:01:00 PM
- As Public Cancer Funding Wavers, Oncology's Brightest Breakthroughs Are Coming From Industry • PR Newswire (US) • 06/12/2025 02:00:00 PM
- As Public Cancer Funding Wavers, Oncology's Brightest Breakthroughs Are Coming From Industry • PR Newswire (Canada) • 06/12/2025 02:00:00 PM
- Shareholders that lost money on Iovance Biotherapeutics, Inc.(IOVA) Urged to Join Class Action - Contact The Gross Law Firm to Learn More • PR Newswire (US) • 06/12/2025 09:45:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2025 09:15:17 PM
- Iovance Biotherapeutics to Present at Upcoming Conference • GlobeNewswire Inc. • 06/10/2025 12:45:00 PM
- IOVA Shareholders Have the Right to Lead the Iovance Biotherapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ELV • PR Newswire (US) • 06/09/2025 02:23:00 PM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM